`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.
`
`SAWAI USA, INC., AND
`
`SAWAI PHARMACEUTICAL CO., LTD.
`
`Petitioners,
`
`V.
`
`BIOGEN MA, INC.
`
`Patent Owner.
`
`Case No. IPR2018-014O31
`
`Patent No. 8,399,514
`
`PETITIONER MYLAN PHARMACEUTICAL INC.’S
`
`UPDATED POWER OF ATTORNEY
`
`1 Case IPR2019-00789 has been joined with this proceeding.
`
`
`
`Pursuant to 37 CPR. § 42.10(b), Petitioner, Mylan Pharmaceuticals Inc.,
`
`hereby appoints the following registered practitioners and counsel admitted pro
`
`hac vice as its attorneys to act on its behalf in all matters associated with the
`
`petition for inter partes review of US. Patent No. 8,399,514, with fiill power to
`
`appoint an associate agent and to transact all business in the United States Patent &
`
`Trademark Office in connections therewith:
`
`
`Lead Counsel
`
`
`
`Brandon M. White
`
`(Reg. No. 52,354)
`Perkins Coie LLP
`
`
`
`
`
`
`Back Up Counsel
`Emily J. Greb
`(Reg. No. 68,244)
`Perkins Coie LLP
`
`700 13th St., NW, Suite 600
`Washington, DC 20005
`BMWhite@perkinscoie.com
`EGreb@perkinscoie.com
`Tel: (202) 654-6206
`Tel: (608) 663-7494
`Fax: (202) 654-9681
`Fax: (608) 283-4494
`
`Additional Back U Counsel
`
`
` Additional Back Up Counsel
`
`33 East Main Street, Suite 201
`
`Madison, WI 53703
`
`
`
`Courtney M. Prochnow
`(Reg. No. 67,639)
`Perkins Coie LLP
`
`David L. Anstaett
`
`(admitted pro hac vice)
`Perkins Coie LLP
`
`
`
`
`
`
`
`
`
`
`
`
`33 East Main Street, Suite 201
`
`633 W. 5th St., Suite 5850
`
`Madison, WI 53703
`
`DAnstaett@perkinscoie.com
`Tel: (608) 663-5408
`Fax: (608) 663-7499
`
`Additional Back U Counsel
`
`Los Angeles, CA 90071-1539
`CProchnow@perkinscoie.com
`Tel: (310) 788-3284
`Fax: (310) 788-3399
`
` Additional Back Up Counsel Shannon M. Bloodworth
`
`Maria A. Stubbings
`(Reg. No. 73,486)
`Perkins Coie LLP
`
`(admitted pro hac vice)
`Perkins Coie LLP
`
`700 13th St., NW, Suite 600
`
`700 13th St., NW, Suite 600
`Washington, DC 20005
`Washington, DC 20005
`Mstubbings@perkinscoie.com
`SBloodworth@perkinscoie.com
`Tel: (202) 654-1742
`Tel: (202) 654-6204
`Fax: (202) 654-9945
`Fax: (202) 654-9135
`
`
`
`Additional Back U n Counsel
`
`Additional Back U Counsel
`
`Michael A. Chajon
`(admitted pro hac vice)
`Perkins Coie LLP
`
`Nathan K. Kelley
`(Reg. No. 45,295)
`Perkins Coie LLP
`
`
`
`
`
`
`
`
`
`
`
`700 13th St., NW, Suite 600
`Washington, DC 20005
`MChajon@perkinscoie.com
`Tel: (202) 654-3316
`Fax: (202) 654-9575
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`700 13th St., NW, Suite 600
`Washington, DC 20005
`NKelley@perkinscoie.com
`Tel: (202) 654-3343
`Fax: (202) 654-9574
`
`
`For: Petitioner Mylan Pharmaceuticals Inc.
`
`Name: 7:“4 U Jenkih:
`
`Title: Agél“. OC/ ' (zlolyal
`
`It L'kl‘icfjlm
`
`Date:
`
`l I
`
`H
`
`Z/Vl
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served a true and
`
`correct copy of the foregoing: PETITIONER MYLAN PHARMACEUTICALS
`
`INC.’S UPDATED POWER OF ATTORNEY by email to the electronic service
`
`addresses for Patent Owners and Petitioner Sawai:
`
`Barbara C. McCurdy
`Mark J. F eldstein
`
`Erin M. Sommers
`
`Pier D. DeRoo
`
`Cora R. Holt
`
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`barbara.mccurdy@finnegan.com
`mark.feldstein@finnegan.com
`erin.sommers@finnegan.com
`pier.deroo@finnegan.com
`cora.holt@finnegan.com
`
`Counselfor Patent Owner
`
`Brian Sodikoff
`
`Christopher B. Ferenc
`Martin S. Masar III
`
`Katten Muchin Rosenman LLP
`
`brian.sodikoff@katten.com
`Christopher.ferenc@katten.com
`martin.masar@katten.com
`
`Counselfor Petitionerfor Sawai USA, Inc., Sawai Pharmaceutical C0,, Ltd.
`
`Dated: November 11, 2019
`
`ls/Bl'andon M. White
`
`Brandon M. White
`
`Reg. No. 52,354
`
`Counselfor Petitioner Mylan Pharmaceuticals Inc.
`
`